<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38668888</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches.</ArticleTitle><Pagination><StartPage>5267</StartPage><EndPage>5286</EndPage><MedlinePgn>5267-5286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01165-5</ELocationID><Abstract><AbstractText>The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has introduced the medical community to the phenomenon of long COVID, a condition characterized by persistent symptoms following the resolution of the acute phase of infection. Among the myriad of symptoms reported by long COVID sufferers, chronic fatigue, cognitive disturbances, and exercise intolerance are predominant, suggesting systemic alterations beyond the initial viral pathology. Emerging evidence has pointed to mitochondrial dysfunction as a potential underpinning mechanism contributing to the persistence and diversity of long COVID symptoms. This review aims to synthesize current findings related to mitochondrial dysfunction in long COVID, exploring its implications for cellular energy deficits, oxidative stress, immune dysregulation, metabolic disturbances, and endothelial dysfunction. Through a comprehensive analysis of the literature, we highlight the significance of mitochondrial health in the pathophysiology of long COVID, drawing parallels with similar clinical syndromes linked to post-infectious states in other diseases where mitochondrial impairment has been implicated. We discuss potential therapeutic strategies targeting mitochondrial function, including pharmacological interventions, lifestyle modifications, exercise, and dietary approaches, and emphasize the need for further research and collaborative efforts to advance our understanding and management of long COVID. This review underscores the critical role of mitochondrial dysfunction in long COVID and calls for a multidisciplinary approach to address the gaps in our knowledge and treatment options for those affected by this condition.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Molnar</LastName><ForeName>Tihamer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lehoczki</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, National Institute for Haematology and Infectious Diseases, South Pest Central Hospital, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fekete</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varnai</LastName><ForeName>Reka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Primary Health Care, Medical School University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zavori</LastName><ForeName>Laszlo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Salisbury NHS Foundation Trust, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdo-Bonyar</LastName><ForeName>Szabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology and Biotechnology, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Immunology and Biotechnology, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berki</LastName><ForeName>T&#xed;mea</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunology and Biotechnology, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csecsei</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4982-2481</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of Pecs, Ret U 2, 7624, Pecs, Hungary. csecsei.peter@pte.hu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezer</LastName><ForeName>Erzsebet</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="Y">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="N">Mitochondrial Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Metabolic disturbances</Keyword><Keyword MajorTopicYN="N">Mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Post-infectious syndromes</Keyword><Keyword MajorTopicYN="N">Therapeutic strategies</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>21</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38668888</ArticleId><ArticleId IdType="pmc">PMC11336094</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01165-5</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01165-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chilunga FP, Appelman B, van Vugt M, Kalverda K, Smeele P, van Es J, Wiersinga WJ, Rostila M, Prins M, Stronks K, et al. Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg Health Eur. 2023;29:100630. 10.1016/j.lanepe.2023.100630. 10.1016/j.lanepe.2023.100630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId><ArticleId IdType="pmc">PMC10079482</ArticleId><ArticleId IdType="pubmed">37261215</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi C, Osborne T, Bailey R, Cooper A, Hollinghurst JP, Akbari A, Crowder R, Peters H, Law RJ, Lewis R, et al. Impact of COVID-19 pandemic on incidence of long-term conditions in Wales: a population data linkage study using primary and secondary care health records. Br J Gen Pract. 2023;73:e332&#x2013;9. 10.3399/BJGP.2022.0353. 10.3399/BJGP.2022.0353</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2022.0353</ArticleId><ArticleId IdType="pmc">PMC9997656</ArticleId><ArticleId IdType="pubmed">37105743</ArticleId></ArticleIdList></Reference><Reference><Citation>Frallonardo L, Segala FV, Chhaganlal KD, Yelshazly M, Novara R, Cotugno S, Guido G, Papagni R, Colpani A, De Vito A, et al. Incidence and burden of long COVID in Africa: a systematic review and meta-analysis. Sci Rep. 2023;13:21482. 10.1038/s41598-023-48258-3. 10.1038/s41598-023-48258-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48258-3</ArticleId><ArticleId IdType="pmc">PMC10700349</ArticleId><ArticleId IdType="pubmed">38057338</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Cristillo V, Camera G, Morotti Colleoni C, Pellitteri G, Viti B, Bianchi E, Gipponi S, Grimoldi M, Valente M, et al. Incidence and long-term functional outcome of neurologic disorders in hospitalized patients with COVID-19 infected with pre-omicron variants. Neurology. 2023;101:e892&#x2013;903. 10.1212/WNL.0000000000207534. 10.1212/WNL.0000000000207534</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207534</ArticleId><ArticleId IdType="pmc">PMC10501088</ArticleId><ArticleId IdType="pubmed">37414564</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J, Grace A, Espinoza R, Kurian A. Incidence of long COVID and associated psychosocial characteristics in a large U.S. city. Soc Psychiatry Psychiatr Epidemiol. 2023;59(4):611&#x2013;9. 10.1007/s00127-023-02548-3. 10.1007/s00127-023-02548-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00127-023-02548-3</ArticleId><ArticleId IdType="pubmed">37606649</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgley R, Winer-Jones J, Bonafede M. Long COVID incidence in a large US ambulatory electronic health record system. Am J Epidemiol. 2023;192:1350&#x2013;7. 10.1093/aje/kwad095. 10.1093/aje/kwad095</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad095</ArticleId><ArticleId IdType="pubmed">37073410</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115:233&#x2013;43. 10.1016/j.jnma.2023.01.016. 10.1016/j.jnma.2023.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2023.01.016</ArticleId><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, Genna V, Smith L, Trott M, Bruyere O, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2023;18:1573&#x2013;81. 10.1007/s11739-022-03164-w. 10.1007/s11739-022-03164-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;54. 10.1016/S2666-7568(22)00245-8. 10.1016/S2666-7568(22)00245-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee N, Sarkar P, Sarkar T. Beyond the acute illness: exploring long COVID and its impact on multiple organ systems. Physiol Int. 2023;110:291&#x2013;310. 10.1556/2060.2023.00256. 10.1556/2060.2023.00256</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2023.00256</ArticleId><ArticleId IdType="pubmed">37943302</ArticleId></ArticleIdList></Reference><Reference><Citation>Gado K, Kovacs AK, Domjan G, Nagy ZZ, Bednarik GD. COVID-19 and the elderly. Physiol Int. 2022. 10.1556/2060.2022.00203. 10.1556/2060.2022.00203</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00203</ArticleId><ArticleId IdType="pubmed">35575987</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterfi A, Meszaros A, Szarvas Z, Penzes M, Fekete M, Feher A, Lehoczki A, Csipo T, Fazekas-Pongor V. Comorbidities and increased mortality of COVID-19 among the elderly: a systematic review. Physiol Int. 2022. 10.1556/2060.2022.00206. 10.1556/2060.2022.00206</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00206</ArticleId><ArticleId IdType="pubmed">35575986</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Wimmer C, Stummer S, Reitelbach J, Bergmann J, Muller F, Jahn K. Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness. Sci Rep. 2024;14:3016. 10.1038/s41598-024-52908-5. 10.1038/s41598-024-52908-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-52908-5</ArticleId><ArticleId IdType="pmc">PMC10847136</ArticleId><ArticleId IdType="pubmed">38321074</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguarta-Val S, Varillas-Delgado D, Lizcano-Alvarez A, Molero-Sanchez A, Melian-Ortiz A, Cano-de-la-Cuerda R, Jimenez-Antona C. Effects of aerobic exercise therapy through nordic walking program in lactate concentrations, fatigue and quality-of-life in patients with long-COVID syndrome: a non-randomized parallel controlled trial. J Clin Med. 2024;13(4):1035. 10.3390/jcm13041035. 10.3390/jcm13041035</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13041035</ArticleId><ArticleId IdType="pmc">PMC10889227</ArticleId><ArticleId IdType="pubmed">38398348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau B, Wentz E, Ni Z, Yenokyan K, Vergara C, Mehta SH, Duggal P. Physical health and mental fatigue disability associated with long COVID: baseline results from a US nationwide cohort. Am J Med. 2023. 10.1016/j.amjmed.2023.08.009. 10.1016/j.amjmed.2023.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.08.009</ArticleId><ArticleId IdType="pmc">PMC10924070</ArticleId><ArticleId IdType="pubmed">37690503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Choi Y, Joung JY, Son CG. Clinical and laboratory characteristics of fatigue-dominant long-COVID subjects: a cross-sectional study. Am J Med. 2024. 10.1016/j.amjmed.2024.01.025. 10.1016/j.amjmed.2024.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2024.01.025</ArticleId><ArticleId IdType="pubmed">38331137</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Varnai R, Schranz D, Zavori L, Peterfi Z, Sipos D, Tokes-Fuzesi M, Illes Z, Buki A, Csecsei P. Severe fatigue and memory impairment are associated with lower serum level of anti-SARS-CoV-2 antibodies in patients with post-COVID symptoms. J Clin Med. 2021;10(19):4337. 10.3390/jcm10194337. 10.3390/jcm10194337</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan. J Clin Med. 2022;11(11):3094. 10.3390/jcm11113094. 10.3390/jcm11113094</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11113094</ArticleId><ArticleId IdType="pmc">PMC9181214</ArticleId><ArticleId IdType="pubmed">35683480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Chang CJ, Hung PH. Possible pathogenesis and prevention of long COVID: SARS-CoV-2-induced mitochondrial disorder. Int J Mol Sci. 2023;24(9):8034. 10.3390/ijms24098034. 10.3390/ijms24098034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098034</ArticleId><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="pubmed">37175745</ArticleId></ArticleIdList></Reference><Reference><Citation>Noonong K, Chatatikun M, Surinkaew S, Kotepui M, Hossain R, Bunluepuech K, Noothong C, Tedasen A, Klangbud WK, Imai M, et al. Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis. Front Immunol. 2023;14:1275001. 10.3389/fimmu.2023.1275001. 10.3389/fimmu.2023.1275001</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1275001</ArticleId><ArticleId IdType="pmc">PMC10766822</ArticleId><ArticleId IdType="pubmed">38187378</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossini E, Concina D, Rinaldi C, Russotto S, Garhwal D, Zeppegno P, Gramaglia C, Kul S, Panella M (2021) Association between plasma redox state/mitochondria function and a flu-like syndrome/COVID-19 in the elderly admitted to a long-term care unit. Front Physiol. 12: 707587 10.3389/fphys.2021.707587</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715756</ArticleId><ArticleId IdType="pubmed">34975514</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X, Ismail NI, Rahman A, Xu D, Chan RWY, Ong SG, Ong SB. Long COVID-19 and the heart: is cardiac mitochondria the missing link? Antioxid Redox Signal. 2023;38:599&#x2013;618. 10.1089/ars.2022.0126. 10.1089/ars.2022.0126</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0126</ArticleId><ArticleId IdType="pmc">PMC10025846</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos I, Soriano V. Mitochondrial damage as cause of long COVID. AIDS Rev. 2023;26:145&#x2013;9. 10.24875/AIDSRev.M23000063. 10.24875/AIDSRev.M23000063</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.M23000063</ArticleId><ArticleId IdType="pubmed">37879634</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan K, Pandey AK, Livingston A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology: could mitochondria be a potential therapeutic target? Mol Biomed. 2021;2:38. 10.1186/s43556-021-00060-1. 10.1186/s43556-021-00060-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-021-00060-1</ArticleId><ArticleId IdType="pmc">PMC8608434</ArticleId><ArticleId IdType="pubmed">34841263</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. 2020;319:C258&#x2013;67. 10.1152/ajpcell.00224.2020. 10.1152/ajpcell.00224.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryback R, Eirin A. Mitochondria, a missing link in COVID-19 heart failure and arrest? Front Cardiovasc Med. 2021;8:830024. 10.3389/fcvm.2021.830024. 10.3389/fcvm.2021.830024</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.830024</ArticleId><ArticleId IdType="pmc">PMC8801453</ArticleId><ArticleId IdType="pubmed">35111835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak BV, Popova EN, Zinovkina LA, Lyamzaev KG, Zinovkin RA. Mitochondria as targets for endothelial protection in COVID-19. Front Physiol. 2020;11:606170. 10.3389/fphys.2020.606170. 10.3389/fphys.2020.606170</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.606170</ArticleId><ArticleId IdType="pmc">PMC7710659</ArticleId><ArticleId IdType="pubmed">33329059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ZZ, Johnson L, Trahtemberg U, Baker A, Huq S, Dufresne J, Bowden P, Miao M, Ho JA, Hsu CC, et al. Mitochondria and cytochrome components released into the plasma of severe COVID-19 and ICU acute respiratory distress syndrome patients. Clin Proteomics. 2023;20:17. 10.1186/s12014-023-09394-0. 10.1186/s12014-023-09394-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-023-09394-0</ArticleId><ArticleId IdType="pmc">PMC10082440</ArticleId><ArticleId IdType="pubmed">37031181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YY, Wei AC. Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. PLoS ONE. 2024;19:e0297664. 10.1371/journal.pone.0297664. 10.1371/journal.pone.0297664</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0297664</ArticleId><ArticleId IdType="pmc">PMC10830027</ArticleId><ArticleId IdType="pubmed">38295140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizjak DA, Ohmayer B, Buhl JL, Schneider EM, Walther P, Calzia E, Jerg A, Matits L, Steinacker JM. Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and post-COVID syndrome. Int J Mol Sci. 2024;25(3):1675. 10.3390/ijms25031675. 10.3390/ijms25031675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25031675</ArticleId><ArticleId IdType="pmc">PMC10855807</ArticleId><ArticleId IdType="pubmed">38338957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowal C, Ghosh S, Ghatak D, De R. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol Cell Biochem. 2023;478:1325&#x2013;43. 10.1007/s11010-022-04593-z. 10.1007/s11010-022-04593-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-022-04593-z</ArticleId><ArticleId IdType="pmc">PMC9617539</ArticleId><ArticleId IdType="pubmed">36308668</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari H, Taghizadeh-Hesary F. COVID-19 induced liver injury from a new perspective: mitochondria. Mitochondrion. 2023;70:103&#x2013;10. 10.1016/j.mito.2023.04.001. 10.1016/j.mito.2023.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2023.04.001</ArticleId><ArticleId IdType="pmc">PMC10088285</ArticleId><ArticleId IdType="pubmed">37054906</ArticleId></ArticleIdList></Reference><Reference><Citation>Streng L, de Wijs CJ, Raat NJH, Specht PAC, Sneiders D, van der Kaaij M, Endeman H, Mik EG, Harms FA. In vivo and ex vivo mitochondrial function in COVID-19 patients on the intensive care unit. Biomedicines. 2022;10(7):1746. 10.3390/biomedicines10071746. 10.3390/biomedicines10071746</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071746</ArticleId><ArticleId IdType="pmc">PMC9313105</ArticleId><ArticleId IdType="pubmed">35885051</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva BSA, Pereira T, Minuzzi LG, Padilha CS, Figueiredo C, Olean-Oliveira T, Dos Santos IVM, von Ah Morano AE, Marchioto Junior O, Ribeiro JPJ, et al. Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level- an observational sub-analysis fit- COVID study. Front Immunol. 2023;14:1212745. 10.3389/fimmu.2023.1212745. 10.3389/fimmu.2023.1212745</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1212745</ArticleId><ArticleId IdType="pmc">PMC10518618</ArticleId><ArticleId IdType="pubmed">37753077</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppercorn K, Edgar CD, Kleffmann T, Tate WP. A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2023;13:22068. 10.1038/s41598-023-49402-9. 10.1038/s41598-023-49402-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49402-9</ArticleId><ArticleId IdType="pmc">PMC10716514</ArticleId><ArticleId IdType="pubmed">38086949</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesjo F, Sayyab S, Karlsson L, Apostolou E, Rosen A, Hedman K, Lerm M. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin Epigenetics. 2022;14:172. 10.1186/s13148-022-01398-1. 10.1186/s13148-022-01398-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId><ArticleId IdType="pmc">PMC9748378</ArticleId><ArticleId IdType="pubmed">36517875</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vitis C, Capalbo C, Torsello A, Napoli C, Salvati V, Loffredo C, Blandino G, Piaggio G, Auciello FR, Pelliccia F, et al. Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients. Antioxid (Basel). 2022;11(10):1998. 10.3390/antiox11101998.10.3390/antiox11101998</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11101998</ArticleId><ArticleId IdType="pmc">PMC9598114</ArticleId><ArticleId IdType="pubmed">36290721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst T, Ryan MC, Liang HJ, Wang JP, Cunningham E, Saleh MG, Kottilil S, Chang L. Neuronal and glial metabolite abnormalities in participants with persistent neuropsychiatric symptoms after COVID-19: a brain proton magnetic resonance spectroscopy study. J Infect Dis. 2023;228:1559&#x2013;70. 10.1093/infdis/jiad309. 10.1093/infdis/jiad309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad309</ArticleId><ArticleId IdType="pmc">PMC10681871</ArticleId><ArticleId IdType="pubmed">37540098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with long COVID-19: a cross-sectional study. J Postgrad Med. 2023;69:162&#x2013;3. 10.4103/jpgm.jpgm_65_23. 10.4103/jpgm.jpgm_65_23</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpgm.jpgm_65_23</ArticleId><ArticleId IdType="pmc">PMC10394531</ArticleId><ArticleId IdType="pubmed">37171415</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, Loo RL, Begum S, Boughton B, Yang R, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. 2021;20:3315&#x2013;29. 10.1021/acs.jproteome.1c00224. 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnigan LEM, Cassar MP, Koziel MJ, Pradines J, Lamlum H, Azer K, Kirby D, Montgomery H, Neubauer S, Valkovic L, Raman B. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine. 2023;59:101946. 10.1016/j.eclinm.2023.101946. 10.1016/j.eclinm.2023.101946</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101946</ArticleId><ArticleId IdType="pmc">PMC10102537</ArticleId><ArticleId IdType="pubmed">37223439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M, Jex N, Thirunavukarasu S, Chowdhary A, Corrado J, Davison J, Tarrant R, Poenar AM, Sharrack N, Parkin A, et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case-control study. J Cardiovasc Magn Reson. 2022;24:50. 10.1186/s12968-022-00887-9. 10.1186/s12968-022-00887-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-022-00887-9</ArticleId><ArticleId IdType="pmc">PMC9464490</ArticleId><ArticleId IdType="pubmed">36089591</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson A, Al Saikhan L, Alghamdi L, Hamill Howes L, Purcell H, Hillman T, Heightman M, Treibel T, Orini M, Bell R, et al. Mechanisms underlying exercise intolerance in long COVID: an accumulation of multisystem dysfunction. Physiol Rep. 2024;12:e15940. 10.14814/phy2.15940. 10.14814/phy2.15940</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15940</ArticleId><ArticleId IdType="pmc">PMC10861355</ArticleId><ArticleId IdType="pubmed">38346773</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Muhammad T, Iqbal MS, Qaisar R. Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men. Exp Gerontol. 2023;171:112034. 10.1016/j.exger.2022.112034. 10.1016/j.exger.2022.112034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2022.112034</ArticleId><ArticleId IdType="pmc">PMC9677556</ArticleId><ArticleId IdType="pubmed">36423404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuteit M, Baskal S, Klawitter S, Dopfer-Jablonka A, Behrens GMN, Muller F, Schroder D, Klawonn F, Steffens S, Tsikas D. Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects. Amino Acids. 2023;55:1173&#x2013;88. 10.1007/s00726-023-03305-1. 10.1007/s00726-023-03305-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-023-03305-1</ArticleId><ArticleId IdType="pmc">PMC10564820</ArticleId><ArticleId IdType="pubmed">37516715</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol. 2022;13:899198. 10.3389/fphar.2022.899198. 10.3389/fphar.2022.899198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Mone P, Trimarco B, Santulli G. Targeting endothelial dysfunction and oxidative stress in Long-COVID. Pharmacol Res. 2022;184:106451. 10.1016/j.phrs.2022.106451. 10.1016/j.phrs.2022.106451</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106451</ArticleId><ArticleId IdType="pmc">PMC9467917</ArticleId><ArticleId IdType="pubmed">36108875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S, Vezzoli A, Garetto G, Paganini M, Camporesi E, Giacon TA, Dellanoce C, Agrimi J, Bosco G. Hyperbaric oxygen therapy counters oxidative stress/inflammation-driven symptoms in long COVID-19 patients: preliminary outcomes. Metabolites. 2023;13(10):1032. 10.3390/metabo13101032. 10.3390/metabo13101032</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13101032</ArticleId><ArticleId IdType="pmc">PMC10608857</ArticleId><ArticleId IdType="pubmed">37887357</ArticleId></ArticleIdList></Reference><Reference><Citation>Medini H, Zirman A, Mishmar D. Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. iScience. 2021;24(12):103471. 10.1016/j.isci.2021.103471. 10.1016/j.isci.2021.103471</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103471</ArticleId><ArticleId IdType="pmc">PMC8599136</ArticleId><ArticleId IdType="pubmed">34812416</ArticleId></ArticleIdList></Reference><Reference><Citation>Blandova G, Janostiakova N, Kodada D, Pastorek M, Liptak R, Hodosy J, Sebekova K, Celec P, Krasnanska G, Elias V, et al. Mitochondrial DNA variability and Covid-19 in the Slovak population. Mitochondrion. 2023;75:101827. 10.1016/j.mito.2023.101827. 10.1016/j.mito.2023.101827</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2023.101827</ArticleId><ArticleId IdType="pubmed">38135240</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamyan L, Elagin V, Vechorko V, Stepanian A, Dashko A, Doroshenko D, Aznaurova Y, Sorokin M, Suntsova M, Drobyshev A, et al. COVID-19-associated inhibition of energy accumulation pathways in human semen samples. F S Sci. 2021;2:355&#x2013;64. 10.1016/j.xfss.2021.07.004. 10.1016/j.xfss.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xfss.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8339600</ArticleId><ArticleId IdType="pubmed">34377996</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: mechanisms and therapeutic targets. MedComm. 2020;2022(3):e157. 10.1002/mco2.157.10.1002/mco2.157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.157</ArticleId><ArticleId IdType="pmc">PMC9363584</ArticleId><ArticleId IdType="pubmed">35958432</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V, Tankisi H. Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): potential neurophysiological biomarkers for these enigmatic entities. Clin Neurophysiol. 2023;147:58&#x2013;9. 10.1016/j.clinph.2023.01.001. 10.1016/j.clinph.2023.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.01.001</ArticleId><ArticleId IdType="pmc">PMC9838078</ArticleId><ArticleId IdType="pubmed">36657309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol. 2022;9:1838&#x2013;57. 10.1002/acn3.51631. 10.1002/acn3.51631</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51631</ArticleId><ArticleId IdType="pmc">PMC9639636</ArticleId><ArticleId IdType="pubmed">36204816</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin M, Sanal-Hayes NEM, Hayes LD, Berry EC, Sculthorpe NF. People with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome exhibit similarly impaired vascular function. Am J Med. 2023. 10.1016/j.amjmed.2023.09.013. 10.1016/j.amjmed.2023.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.09.013</ArticleId><ArticleId IdType="pubmed">37832757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, Eggert LE, Sharifi H, Horomanski A, Subramanian A, et al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747. 10.3389/fneur.2023.1090747. 10.3389/fneur.2023.1090747</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 1991;83:61&#x2013;5. 10.1007/BF00294431. 10.1007/BF00294431</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00294431</ArticleId><ArticleId IdType="pubmed">1792865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med. 2021;7:14&#x2013;26. 10.1016/j.cdtm.2020.11.002. 10.1016/j.cdtm.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang PY, Ma J, Kim YC, Son AY, Syed AM, Liu C, Mori MP, Huffstutler RD, Stolinski JL, Talagala SL, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2023;120:e2302738120. 10.1073/pnas.2302738120. 10.1073/pnas.2302738120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2302738120</ArticleId><ArticleId IdType="pmc">PMC10450651</ArticleId><ArticleId IdType="pubmed">37579159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1beta. Eur J Neurosci. 2022;56:5784&#x2013;94. 10.1111/ejn.15828. 10.1111/ejn.15828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15828</ArticleId><ArticleId IdType="pubmed">36153118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020;18:365. 10.1186/s12967-020-02533-3. 10.1186/s12967-020-02533-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson I, Palmer J, Apostolou E, Gottfries CG, Rizwan M, Dahle C, Rosen A. Metabolic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome not due to anti-mitochondrial antibodies. Front Med (Lausanne). 2020;7:108. 10.3389/fmed.2020.00108. 10.3389/fmed.2020.00108</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00108</ArticleId><ArticleId IdType="pmc">PMC7136523</ArticleId><ArticleId IdType="pubmed">32296708</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29:19&#x2013;36. 10.1007/s11011-013-9435-x. 10.1007/s11011-013-9435-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType="pubmed">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R, Balinas C, Holden S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2021;19:81. 10.1186/s12967-021-02742-4. 10.1186/s12967-021-02742-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02742-4</ArticleId><ArticleId IdType="pmc">PMC7890871</ArticleId><ArticleId IdType="pubmed">33596913</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J Transl Med. 2020;18:290. 10.1186/s12967-020-02452-3. 10.1186/s12967-020-02452-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02452-3</ArticleId><ArticleId IdType="pmc">PMC7392668</ArticleId><ArticleId IdType="pubmed">32727475</ArticleId></ArticleIdList></Reference><Reference><Citation>Billing-Ross P, Germain A, Ye K, Keinan A, Gu Z, Hanson MR. Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2016;14:19. 10.1186/s12967-016-0771-6. 10.1186/s12967-016-0771-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-0771-6</ArticleId><ArticleId IdType="pmc">PMC4719218</ArticleId><ArticleId IdType="pubmed">26791940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D, Hargreaves IP, Domingo JC, Castro-Marrero J. Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview. Int J Mol Sci. 2024;25(1):574. 10.3390/ijms25010574. 10.3390/ijms25010574</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25010574</ArticleId><ArticleId IdType="pmc">PMC10779395</ArticleId><ArticleId IdType="pubmed">38203745</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome. Neuro Endocrinol Lett. 2009;30:715&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20035260</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Sci Monit. 2011;17(4):SC11&#x2013;5. 10.12659/msm.881699. 10.12659/msm.881699</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.881699</ArticleId><ArticleId IdType="pmc">PMC3539515</ArticleId><ArticleId IdType="pubmed">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118:34. 10.1073/pnas.2024358118.10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Geebelen L, Lernout T, Devleesschauwer B, Kabamba-Mukadi B, Saegeman V, Belkhir L, De Munter P, Dubois B, Westhovens R, Humtick Hospital G, et al. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016&#x2013;2020). BMC Infect Dis. 2022;22:756. 10.1186/s12879-022-07686-8. 10.1186/s12879-022-07686-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07686-8</ArticleId><ArticleId IdType="pmc">PMC9518937</ArticleId><ArticleId IdType="pubmed">36171561</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock BN, Gherezghiher TB, Hilario JD, Kellermann GH. New insights into Lyme disease. Redox Biol. 2015;5:66&#x2013;70. 10.1016/j.redox.2015.03.002. 10.1016/j.redox.2015.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.03.002</ArticleId><ArticleId IdType="pmc">PMC4392059</ArticleId><ArticleId IdType="pubmed">25838067</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Whistler T, Cameron B, Hickie IB, Reeves WC, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis. 2006;6:15. 10.1186/1471-2334-6-15. 10.1186/1471-2334-6-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-15</ArticleId><ArticleId IdType="pmc">PMC1373655</ArticleId><ArticleId IdType="pubmed">16448567</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, Tjade T, Oie MG, Wyller VBB. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: a prospective cohort study. Brain Behav Immun. 2019;75:94&#x2013;100. 10.1016/j.bbi.2018.09.023. 10.1016/j.bbi.2018.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.09.023</ArticleId><ArticleId IdType="pubmed">30261303</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodwall EM, Pedersen M, Asprusten TT, Wyller VBB. Pain in adolescent chronic fatigue following Epstein-Barr virus infection. Scand J Pain. 2020;20:765&#x2013;73. 10.1515/sjpain-2020-0031. 10.1515/sjpain-2020-0031</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/sjpain-2020-0031</ArticleId><ArticleId IdType="pubmed">32892183</ArticleId></ArticleIdList></Reference><Reference><Citation>LaJeunesse DR, Brooks K, Adamson AL. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. Biochem Biophys Res Commun. 2005;333:438&#x2013;42. 10.1016/j.bbrc.2005.05.120. 10.1016/j.bbrc.2005.05.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.05.120</ArticleId><ArticleId IdType="pubmed">15950179</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna G, Soman Pillai V, Valiya VM. Upregulation of GLS1 isoforms KGA and GAC facilitates mitochondrial metabolism and cell proliferation in Epstein-Barr virus infected cells. Viruses. 2020;12(8):811. 10.3390/v12080811. 10.3390/v12080811</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12080811</ArticleId><ArticleId IdType="pmc">PMC7472350</ArticleId><ArticleId IdType="pubmed">32727118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawanishi M, Tada-Oikawa S, Kawanishi S. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem Biophys Res Commun. 2002;297:682&#x2013;7. 10.1016/s0006-291x(02)02261-1. 10.1016/s0006-291x(02)02261-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(02)02261-1</ArticleId><ArticleId IdType="pubmed">12270148</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Roerink ME, Jansen AFM, Keijmel SP, Gacesa R, Li Y, Joosten LAB, van der Meer JWM, Netea MG, Bleeker-Rovers CP, Xu CJ. Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome. J Transl Med. 2020;18:448. 10.1186/s12967-020-02585-5. 10.1186/s12967-020-02585-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02585-5</ArticleId><ArticleId IdType="pmc">PMC7690002</ArticleId><ArticleId IdType="pubmed">33243243</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Jansen AFM, Keijmel SP, Ter Horst R, Roerink ME, Novakovic B, Joosten LAB, van der Meer JWM, Netea MG, Bleeker-Rovers CP. A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome. J Transl Med. 2019;17:157. 10.1186/s12967-019-1906-3. 10.1186/s12967-019-1906-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1906-3</ArticleId><ArticleId IdType="pmc">PMC6518812</ArticleId><ArticleId IdType="pubmed">31088495</ArticleId></ArticleIdList></Reference><Reference><Citation>Elesela S, Lukacs NW. Role of mitochondria in viral infections. Life (Basel). 2021;11(3):232. 10.3390/life11030232. 10.3390/life11030232</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11030232</ArticleId><ArticleId IdType="pmc">PMC7998235</ArticleId><ArticleId IdType="pubmed">33799853</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S, Das N, Mukherjee P. Picking up a fight: fine tuning mitochondrial innate immune defenses against RNA viruses. Front Microbiol. 2020;11:1990. 10.3389/fmicb.2020.01990. 10.3389/fmicb.2020.01990</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01990</ArticleId><ArticleId IdType="pmc">PMC7487669</ArticleId><ArticleId IdType="pubmed">32983015</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Aguayo JJ, Garza-Veloz I, Vargas-Rodriguez JR, Martinez-Vazquez MC, Avila-Carrasco L, Bernal-Silva S, Gonzalez-Fuentes C, Comas-Garcia A, Alvarado-Hernandez DE, Centeno-Ramirez ASH, et al. Peripheral blood mitochondrial DNA levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19. Front Cell Infect Microbiol. 2021;11:754708. 10.3389/fcimb.2021.754708. 10.3389/fcimb.2021.754708</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.754708</ArticleId><ArticleId IdType="pmc">PMC8716733</ArticleId><ArticleId IdType="pubmed">34976854</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O&#x2019;Halloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6:4. 10.1172/jci.insight.143299.10.1172/jci.insight.143299</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143299</ArticleId><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Aguayo JJ, Garza-Veloz I, Badillo-Almaraz JI, Bernal-Silva S, Martinez-Vazquez MC, Juarez-Alcala V, Vargas-Rodriguez JR, Gaeta-Velasco ML, Gonzalez-Fuentes C, Avila-Carrasco L, Martinez-Fierro ML. Mitochondria and mitochondrial DNA: key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Med (Kaunas). 2021;57(9):928. 10.3390/medicina57090928.10.3390/medicina57090928</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090928</ArticleId><ArticleId IdType="pmc">PMC8471487</ArticleId><ArticleId IdType="pubmed">34577851</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SL, Dasgupta A, Chen KH, Wu D, Baid K, Mamatis JE, Gonzalez V, Read A, Bentley RE, Martin AY, et al. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. Redox Biol. 2022;58:102508. 10.1016/j.redox.2022.102508. 10.1016/j.redox.2022.102508</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102508</ArticleId><ArticleId IdType="pmc">PMC9558649</ArticleId><ArticleId IdType="pubmed">36334378</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart H, Lu Y, O&#x2019;Keefe S, Valpadashi A, Cruz-Zaragoza LD, Michel HA, Nguyen SK, Carnell GW, Lukhovitskaya N, Milligan R, et al. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity. iScience. 2023;26(11):108080. 10.1016/j.isci.2023.108080. 10.1016/j.isci.2023.108080</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.108080</ArticleId><ArticleId IdType="pmc">PMC10583119</ArticleId><ArticleId IdType="pubmed">37860693</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Hou P, Ma W, Wang X, Wang H, Yu Z, Chang H, Wang T, Jin S, Wang X, et al. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol. 2022;19:67&#x2013;78. 10.1038/s41423-021-00807-4. 10.1038/s41423-021-00807-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00807-4</ArticleId><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, Sepulveda N, Mathias da Fonseca DL, Baiocchi GC, Marques AHC, et al. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in post COVID syndrome correlate with symptom severity. Front Immunol. 2022;13:981532. 10.3389/fimmu.2022.981532. 10.3389/fimmu.2022.981532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Nagy B Jr., Raduly AP, Manyine IS, Martha L, Erdosi G, Sipka S, Jr., Enyedi E, Szabo AA, Polik Z, et al. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Gerosci. 2022;44:2347&#x2013;60. 10.1007/s11357-022-00649-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483490</ArticleId><ArticleId IdType="pubmed">36112333</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert FS, Stervbo U, Wiemers L, Skrzypczyk S, Hogeweg M, Bertram S, Kurek J, Anft M, Westhoff TH, Babel N. Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev. 2023;22:103445. 10.1016/j.autrev.2023.103445. 10.1016/j.autrev.2023.103445</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103445</ArticleId><ArticleId IdType="pubmed">37689093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Nilsson AC, Wamberg C, Jensen VVS, Petersen CB, Hejl AM, Lebech AM, Theut AM, Jorgensen CS, et al. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study. Brain Commun. 2023;5(5):fcad274. 10.1093/braincomms/fcad274. 10.1093/braincomms/fcad274</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad274</ArticleId><ArticleId IdType="pmc">PMC10613856</ArticleId><ArticleId IdType="pubmed">37908236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Yoon T, Ha JW, Kim J, Lee KH, Lee JA, Kim CH, Lee SW, Kim JH, Ahn JY, et al. Prevalence, clinical significance, and persistence of autoantibodies in COVID-19. Virol J. 2023;20:236. 10.1186/s12985-023-02191-z. 10.1186/s12985-023-02191-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02191-z</ArticleId><ArticleId IdType="pmc">PMC10577963</ArticleId><ArticleId IdType="pubmed">37845706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca DLM, Filgueiras IS, Marques AHC, Vojdani E, Halpert G, Ostrinski Y, Baiocchi GC, Placa DR, Freire PP, Pour SZ, et al. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach. NPJ Aging. 2023;9:21. 10.1038/s41514-023-00118-0. 10.1038/s41514-023-00118-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41514-023-00118-0</ArticleId><ArticleId IdType="pmc">PMC10449916</ArticleId><ArticleId IdType="pubmed">37620330</ArticleId></ArticleIdList></Reference><Reference><Citation>Credle JJ, Gunn J, Sangkhapreecha P, Monaco DR, Zheng XA, Tsai HJ, Wilbon A, Morgenlander WR, Rastegar A, Dong Y, et al. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat Biomed Eng. 2022;6:992&#x2013;1003. 10.1038/s41551-022-00925-y. 10.1038/s41551-022-00925-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-022-00925-y</ArticleId><ArticleId IdType="pmc">PMC10034860</ArticleId><ArticleId IdType="pubmed">35986181</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, et al. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022;7:9. 10.1172/jci.insight.158362.10.1172/jci.insight.158362</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158362</ArticleId><ArticleId IdType="pmc">PMC9090251</ArticleId><ArticleId IdType="pubmed">35349483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun. 2022;13:1220. 10.1038/s41467-022-28905-5. 10.1038/s41467-022-28905-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenegro YHA, Bobermin LD, Sesterheim P, Salvato RS, Anschau F, de Oliveira MJS, Wyse ATS, Netto CA, Goncalves CS, Quincozes-Santos A, Leipnitz G. Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats. J Neurovirol. 2023;29:577&#x2013;87. 10.1007/s13365-023-01156-w. 10.1007/s13365-023-01156-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01156-w</ArticleId><ArticleId IdType="pubmed">37501054</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Florio DN, Beetler DJ, McCabe EJ, Sin J, Ikezu T, Fairweather D. Mitochondrial extracellular vesicles, autoimmunity and myocarditis. Front Immunol. 2024;15:1374796. 10.3389/fimmu.2024.1374796. 10.3389/fimmu.2024.1374796</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1374796</ArticleId><ArticleId IdType="pmc">PMC10972887</ArticleId><ArticleId IdType="pubmed">38550582</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Shahbaz S, Luo X, Osman M, Redmond D, Cohen Tervaert JW, Li L, Elahi S. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol. 2024;15:1341843. 10.3389/fimmu.2024.1341843. 10.3389/fimmu.2024.1341843</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId><ArticleId IdType="pmc">PMC10830702</ArticleId><ArticleId IdType="pubmed">38304426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbalova Z, Kucharska J, Palacka P, Rausova Z, Langsjoen PH, Langsjoen AM, Gvozdjakova A. Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. Bratisl Lek Listy. 2022;123:9&#x2013;15. 10.4149/BLL_2022_002. 10.4149/BLL_2022_002</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2022_002</ArticleId><ArticleId IdType="pubmed">34967652</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasada Kabekkodu S, Chakrabarty S, Jayaram P, Mallya S, Thangaraj K, Singh KK, Satyamoorthy K. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: implications for post-COVID complications. Mitochondrion. 2023;69:43&#x2013;56. 10.1016/j.mito.2023.01.005. 10.1016/j.mito.2023.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2023.01.005</ArticleId><ArticleId IdType="pmc">PMC9854144</ArticleId><ArticleId IdType="pubmed">36690315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathol Oncol Res. 2024;23:30. 10.3389/pore.2024.1611623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10922957</ArticleId><ArticleId IdType="pubmed">38463143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol. 1997;29:1067&#x2013;73. 10.1016/s0735-1097(97)00015-6. 10.1016/s0735-1097(97)00015-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(97)00015-6</ArticleId><ArticleId IdType="pubmed">9120161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen TS, Rolim NP, Fischer T, Baekkerud FH, Medeiros A, Werner S, Bronstad E, Rognmo O, Mangner N, Linke A, et al. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J Heart Fail. 2015;17:263&#x2013;72. 10.1002/ejhf.239. 10.1002/ejhf.239</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.239</ArticleId><ArticleId IdType="pubmed">25655080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack MN. Tackling inflammation at its source in heart failure: are mitochondria the key? JACC Basic Transl Sci. 2022;7:1197&#x2013;9. 10.1016/j.jacbts.2022.07.008. 10.1016/j.jacbts.2022.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2022.07.008</ArticleId><ArticleId IdType="pmc">PMC9831925</ArticleId><ArticleId IdType="pubmed">36644286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31&#x2013;41. 10.1016/j.yjmcc.2012.09.002. 10.1016/j.yjmcc.2012.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2012.09.002</ArticleId><ArticleId IdType="pmc">PMC3805050</ArticleId><ArticleId IdType="pubmed">22982369</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res. 2010;88:40&#x2013;50. 10.1093/cvr/cvq240. 10.1093/cvr/cvq240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq240</ArticleId><ArticleId IdType="pmc">PMC3025720</ArticleId><ArticleId IdType="pubmed">20668004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L, Gopireddy RR, Perkins G, Zhang H, Timofeyev V, Lyu Y, Diloretto DA, Trinh P, Sirish P, Overton JL, et al. Disruption of mitochondria-sarcoplasmic reticulum microdomain connectomics contributes to sinus node dysfunction in heart failure. Proc Natl Acad Sci U S A. 2022;119:e2206708119. 10.1073/pnas.2206708119. 10.1073/pnas.2206708119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2206708119</ArticleId><ArticleId IdType="pmc">PMC9456763</ArticleId><ArticleId IdType="pubmed">36044551</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin-Garcia J, Akhmedov AT, Moe GW. Mitochondria in heart failure: the emerging role of mitochondrial dynamics. Heart Fail Rev. 2013;18:439&#x2013;56. 10.1007/s10741-012-9330-2. 10.1007/s10741-012-9330-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9330-2</ArticleId><ArticleId IdType="pubmed">22707247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol. 2013;61:599&#x2013;610. 10.1016/j.jacc.2012.08.1021. 10.1016/j.jacc.2012.08.1021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.08.1021</ArticleId><ArticleId IdType="pmc">PMC3594689</ArticleId><ArticleId IdType="pubmed">23219298</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O&#x2019;Keeffe E, Zaporojan L, O&#x2019;Callaghan J, Thomson B, Connolly E, Argue R, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024. 10.1038/s41593-024-01576-9. 10.1038/s41593-024-01576-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale S, Beretta P, Morbini P. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol. 2021;93:61&#x2013;3. 10.1002/jmv.26119. 10.1002/jmv.26119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26119</ArticleId><ArticleId IdType="pmc">PMC7300801</ArticleId><ArticleId IdType="pubmed">32492199</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon-Cama V, Montero-Gonzalez T, Acosta-Medina EF, Guillen-Nieto G, Berlanga-Acosta J, Fernandez-Ortega C, Alfonso-Falcon A, Gilva-Rodriguez N, Lopez-Nocedo L, Cremata-Garcia D, et al. Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis. Arch Virol. 2023;168:96. 10.1007/s00705-023-05711-y. 10.1007/s00705-023-05711-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-023-05711-y</ArticleId><ArticleId IdType="pmc">PMC9968404</ArticleId><ArticleId IdType="pubmed">36842152</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Kanamarlapudi V. Molecular analysis of SARS-CoV-2 spike protein-induced endothelial cell permeability and vWF secretion. Int J Mol Sci. 2023;24(6):5664. 10.3390/ijms24065664. 10.3390/ijms24065664</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065664</ArticleId><ArticleId IdType="pmc">PMC10053386</ArticleId><ArticleId IdType="pubmed">36982738</ArticleId></ArticleIdList></Reference><Reference><Citation>Jud P, Gressenberger P, Muster V, Avian A, Meinitzer A, Strohmaier H, Sourij H, Raggam RB, Stradner MH, Demel U, et al. Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection-a cross-sectional study. Front Cardiovasc Med. 2021;8:750887. 10.3389/fcvm.2021.750887. 10.3389/fcvm.2021.750887</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.750887</ArticleId><ArticleId IdType="pmc">PMC8549830</ArticleId><ArticleId IdType="pubmed">34722682</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, Appelt-Menzel A, Cubukova A, Barenberg J, Leu J, et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports. 2022;17:307&#x2013;20. 10.1016/j.stemcr.2021.12.011. 10.1016/j.stemcr.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, Worsdorfer P, Midkiff CC, Mudd J, Belyaeva E, et al. SARS-CoV-2 infects endothelial cells in vivo and in vitro. Front Cell Infect Microbiol. 2021;11:701278. 10.3389/fcimb.2021.701278. 10.3389/fcimb.2021.701278</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.701278</ArticleId><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezoh G, Crowther NJ. Endothelial dysfunction as a primary consequence of SARS-CoV-2 infection. Adv Exp Med Biol. 2021;1321:33&#x2013;43. 10.1007/978-3-030-59261-5_3. 10.1007/978-3-030-59261-5_3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-59261-5_3</ArticleId><ArticleId IdType="pubmed">33656711</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta CS, Torices S, da Rosa BG, Marcos AC, Alvarez-Rosa L, Siqueira M, Moreno-Rodriguez T, Matos ADR, Caetano BC, Martins J, et al. Human brain microvascular endothelial cells exposure to SARS-CoV-2 leads to inflammatory activation through NF-kappaB non-canonical pathway and mitochondrial remodeling. Viruses. 2023;15(3):745. 10.3390/v15030745. 10.3390/v15030745</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima Y, Hader SN, Hanson AJ, Zhang DX, Sparapani R, Gutterman DD, Beyer AM. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res. 2021. 10.1093/cvr/cvab339.10.1093/cvr/cvab339</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab339</ArticleId><ArticleId IdType="pmc">PMC8689948</ArticleId><ArticleId IdType="pubmed">34755839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelisek J, Reutersberg B, Greber UF, Zimmermann A. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. Clin Sci (Lond). 2022;136:1571&#x2013;90. 10.1042/CS20220235. 10.1042/CS20220235</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20220235</ArticleId><ArticleId IdType="pmc">PMC9652506</ArticleId><ArticleId IdType="pubmed">36367091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesti A, Danics K, Glasz T, Varkonyi T, Barbai T, Reszegi A, Kovalszky I, Valyi-Nagy I, Dobi D, Lotz G, et al. Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies. Gerosci. 2023;45:1015&#x2013;31. 10.1007/s11357-022-00700-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9759055</ArticleId><ArticleId IdType="pubmed">36527584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner JUG, Bojkova D, Shumliakivska M, Luxan G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol. 2021;116:42. 10.1007/s00395-021-00882-8. 10.1007/s00395-021-00882-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00882-8</ArticleId><ArticleId IdType="pmc">PMC8256413</ArticleId><ArticleId IdType="pubmed">34224022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, Muller-Fielitz H, Schuster R, Zille M, Muller K, Krohn M, Korbelin J, Zhang L, Ozorhan U, et al. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021;24:1522&#x2013;33. 10.1038/s41593-021-00926-1. 10.1038/s41593-021-00926-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RC, Huang K, Zhang HP, Li L, Zhang YF, Tan C, Chen HC, Jin ML, Wang XR. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation. 2022;19:149. 10.1186/s12974-022-02514-x. 10.1186/s12974-022-02514-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Addabbo F, Ratliff B, Park HC, Kuo MC, Ungvari Z, Csiszar A, Krasnikov B, Sodhi K, Zhang F, Nasjletti A, Goligorsky MS. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Am J Pathol. 2009;174:34&#x2013;43. 10.2353/ajpath.2009.080650. 10.2353/ajpath.2009.080650</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.080650</ArticleId><ArticleId IdType="pmc">PMC2631316</ArticleId><ArticleId IdType="pubmed">19095954</ArticleId></ArticleIdList></Reference><Reference><Citation>Coletta C, Modis K, Olah G, Brunyanszki A, Herzig DS, Sherwood ER, Ungvari Z, Szabo C. Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture. Crit Care. 2014;18:511. 10.1186/s13054-014-0511-3. 10.1186/s13054-014-0511-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0511-3</ArticleId><ArticleId IdType="pmc">PMC4177582</ArticleId><ArticleId IdType="pubmed">25223540</ArticleId></ArticleIdList></Reference><Reference><Citation>Csiszar A, Wang M, Lakatta EG, Ungvari ZI. Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B. J Appl Physiol. 2008;105(4):1333&#x2013;41. 10.1152/japplphysiol.90470.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.90470.2008</ArticleId><ArticleId IdType="pmc">PMC2576023</ArticleId><ArticleId IdType="pubmed">18599677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109&#x2013;24. 10.1161/CIRCRESAHA.111.246140. 10.1161/CIRCRESAHA.111.246140</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.246140</ArticleId><ArticleId IdType="pmc">PMC3867977</ArticleId><ArticleId IdType="pubmed">22499901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Nyul-Toth A, Balasubramanian P, Tarantini S, Ahire C, Yabluchanskiy A, Csipo T, Farkas E, Wren JD, Garman L, et al. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience. 2020. 10.1007/s11357-020-00165-5. 10.1007/s11357-020-00165-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00165-5</ArticleId><ArticleId IdType="pmc">PMC7206476</ArticleId><ArticleId IdType="pubmed">32056076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini S, Valcarcel-Ares MN, Toth P, Yabluchanskiy A, Tucsek Z, Kiss T, Hertelendy P, Kinter M, Ballabh P, Sule Z, et al. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol. 2019;24:101192. 10.1016/j.redox.2019.101192. 10.1016/j.redox.2019.101192</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101192</ArticleId><ArticleId IdType="pmc">PMC6477631</ArticleId><ArticleId IdType="pubmed">31015147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Fulop GA, Hertelendy P, Gautam T, Farkas E, Perz A, Rabinovitch PS, Sonntag WE, et al. Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice. Aging Cell. 2018;17:2. 10.1111/acel.12731.10.1111/acel.12731</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12731</ArticleId><ArticleId IdType="pmc">PMC5847870</ArticleId><ArticleId IdType="pubmed">29405550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P, Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297:H1876-1881. 10.1152/ajpheart.00375.2009. 10.1152/ajpheart.00375.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00375.2009</ArticleId><ArticleId IdType="pmc">PMC2781360</ArticleId><ArticleId IdType="pubmed">19749157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849&#x2013;67. 10.1161/CIRCRESAHA.118.311378. 10.1161/CIRCRESAHA.118.311378</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.311378</ArticleId><ArticleId IdType="pmc">PMC6248882</ArticleId><ArticleId IdType="pubmed">30355080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari ZI, Labinskyy N, Gupte SA, Chander PN, Edwards JG, Csiszar A. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am J Physiol Heart Circ Physiol. 2008;294:H2121-2128. 10.1152/ajpheart.00012.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00012.2008</ArticleId><ArticleId IdType="pubmed">18326800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari ZI, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith KE, Csiszar A. Increased mitochondrial H2O2 production promotes endothelial NF-kB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293:H37-47. 10.1152/ajpheart.01346.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01346.2006</ArticleId><ArticleId IdType="pubmed">17416599</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat Commun. 2023;14:983. 10.1038/s41467-023-36223-7. 10.1038/s41467-023-36223-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Martin-Guerrero JD, Navarro-Pardo E, Torres-Macho J, Guijarro C, Pellicer-Valero OJ. Exploring the recovery curve for gastrointestinal symptoms from the acute COVID-19 phase to long-term post-COVID: The LONG-COVID-EXP-CM Multicenter Study. J Med Virol. 2022;94:2925&#x2013;7. 10.1002/jmv.27727. 10.1002/jmv.27727</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27727</ArticleId><ArticleId IdType="pmc">PMC9088575</ArticleId><ArticleId IdType="pubmed">35315087</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpenko IL, Valuev-Elliston VT, Ivanova ON, Smirnova OA, Ivanov AV. Peroxiredoxins-the underrated actors during virus-induced oxidative stress. Antioxid (Basel). 2021;10(6):977. 10.3390/antiox10060977.10.3390/antiox10060977</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10060977</ArticleId><ArticleId IdType="pmc">PMC8234473</ArticleId><ArticleId IdType="pubmed">34207367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox AG, Winterbourn CC, Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J. 2009;425:313&#x2013;25. 10.1042/BJ20091541. 10.1042/BJ20091541</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091541</ArticleId><ArticleId IdType="pubmed">20025614</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao B, Wang J, Xie J, Niu Y, Ye S, Wan Q, Ye Q. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach. Int J Mol Med. 2012;29:832&#x2013;40. 10.3892/ijmm.2012.916. 10.3892/ijmm.2012.916</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2012.916</ArticleId><ArticleId IdType="pubmed">22344546</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, Wu LL, Yang JR, Chen XF, Zhang Y, Chen ZQ, Liu CL, Chi SY, Zheng JY, Huang HX, et al. Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients. Asian Pac J Cancer Prev. 2014;15:2979&#x2013;86. 10.7314/apjcp.2014.15.7.2979. 10.7314/apjcp.2014.15.7.2979</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/apjcp.2014.15.7.2979</ArticleId><ArticleId IdType="pubmed">24815434</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE). In National Institute for Health and Care Excellence: Clinical Guidelines. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. J Psychosom Res. 1993;37:147&#x2013;53. 10.1016/0022-3999(93)90081-p. 10.1016/0022-3999(93)90081-p</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-p</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, Rezek SA, Spruit MA, Vehreschild J, Siegerink B. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. 10.1183/13993003.01494-2020. 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, Hallqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. &#x2018;The long tail of Covid-19&#x2019; - the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349. 10.12688/f1000research.27287.2. 10.12688/f1000research.27287.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradbury J, Wilkinson S, Schloss J. Nutritional support during long COVID: a systematic scoping review. J Integr Complement Med. 2023;29:695&#x2013;704. 10.1089/jicm.2022.0821. 10.1089/jicm.2022.0821</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jicm.2022.0821</ArticleId><ArticleId IdType="pubmed">37102680</ArticleId></ArticleIdList></Reference><Reference><Citation>Akanchise T, Angelova A. Potential of nano-antioxidants and nanomedicine for recovery from neurological disorders linked to long COVID syndrome. Antioxid (Basel). 2023;12(2):393. 10.3390/antiox12020393.10.3390/antiox12020393</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12020393</ArticleId><ArticleId IdType="pmc">PMC9952277</ArticleId><ArticleId IdType="pubmed">36829952</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlidou E, Poulios E, Papadopoulou SK, Fasoulas A, Dakanalis A, Giaginis C. Clinical evidence on the potential beneficial effects of diet and dietary supplements against COVID-19 infection risk and symptoms&#x2019; severity. Med Sci (Basel). 2024;12(1):11. 10.3390/medsci12010011. 10.3390/medsci12010011</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci12010011</ArticleId><ArticleId IdType="pmc">PMC10885051</ArticleId><ArticleId IdType="pubmed">38390861</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao MT, Wu CC, Wu SV, Lee MC, Hu WC, Tsai KW, Yang CH, Lu CL, Chiu SK, Lu KC. Resveratrol as an adjunctive therapy for excessive oxidative stress in aging COVID-19 patients. Antioxid (Basel). 2021;10(9):1440. 10.3390/antiox10091440.10.3390/antiox10091440</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10091440</ArticleId><ArticleId IdType="pmc">PMC8471532</ArticleId><ArticleId IdType="pubmed">34573071</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaziri-Harami R, Delkash P. Can l-carnitine reduce post-COVID-19 fatigue? Ann Med Surg (Lond). 2022;73:103145. 10.1016/j.amsu.2021.103145. 10.1016/j.amsu.2021.103145</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.103145</ArticleId><ArticleId IdType="pmc">PMC8667465</ArticleId><ArticleId IdType="pubmed">34925826</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z, Dautaj A, Nodari S, Fioretti F, Dhuli K, Anpilogov K, Lorusso L, Paolacci S, Michelini S, Guda T, et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur Rev Med Pharmacol Sci. 2021;25:67&#x2013;73. 10.26355/eurrev_202112_27335. 10.26355/eurrev_202112_27335</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27335</ArticleId><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino J, Baur JA, Imai SI. NAD(+) intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27:513&#x2013;28. 10.1016/j.cmet.2017.11.002. 10.1016/j.cmet.2017.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.11.002</ArticleId><ArticleId IdType="pmc">PMC5842119</ArticleId><ArticleId IdType="pubmed">29249689</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederick DW, Davis JG, Davila A Jr, Agarwal B, Michan S, Puchowicz MA, Nakamaru-Ogiso E, Baur JA. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. J Biol Chem. 2015;290:1546&#x2013;58. 10.1074/jbc.M114.579565. 10.1074/jbc.M114.579565</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.579565</ArticleId><ArticleId IdType="pmc">PMC4340401</ArticleId><ArticleId IdType="pubmed">25411251</ArticleId></ArticleIdList></Reference><Reference><Citation>Davila A, Liu L, Chellappa K, Redpath P, Nakamaru-Ogiso E, Paolella LM, Zhang Z, Migaud ME, Rabinowitz JD, Baur JA. Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. Elife. 2018;12(7):e33246.&#xa0;10.7554/eLife.33246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013257</ArticleId><ArticleId IdType="pubmed">29893687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Nyul-Toth A, Balasubramanian P, Tarantini S, Ahire C, Yabluchanskiy A, Csipo T, Farkas E, Wren JD, Garman L, et al. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience. 2020;42:527&#x2013;46. 10.1007/s11357-020-00165-5. 10.1007/s11357-020-00165-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00165-5</ArticleId><ArticleId IdType="pmc">PMC7206476</ArticleId><ArticleId IdType="pubmed">32056076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Giles CB, Tarantini S, Yabluchanskiy A, Balasubramanian P, Gautam T, Csipo T, Nyul-Toth A, Lipecz A, Szabo C, et al. Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects. Geroscience. 2019;41:419&#x2013;39. 10.1007/s11357-019-00095-x. 10.1007/s11357-019-00095-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-019-00095-x</ArticleId><ArticleId IdType="pmc">PMC6815288</ArticleId><ArticleId IdType="pubmed">31463647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Balasubramanian P, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Csipo T, Lipecz A, Reglodi D, Zhang XA, Bari F, et al. Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. Geroscience. 2019;41:619&#x2013;30. 10.1007/s11357-019-00074-2. 10.1007/s11357-019-00074-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-019-00074-2</ArticleId><ArticleId IdType="pmc">PMC6885080</ArticleId><ArticleId IdType="pubmed">31144244</ArticleId></ArticleIdList></Reference><Reference><Citation>Block T, Kuo J. Rationale for nicotinamide adenine dinucleotide (NAD+) metabolome disruption as a pathogenic mechanism of post-acute COVID-19 syndrome. Clin Pathol. 2022;15:2632010X2211069. 10.1177/2632010X221106986.10.1177/2632010X221106986</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2632010X221106986</ArticleId><ArticleId IdType="pmc">PMC9234841</ArticleId><ArticleId IdType="pubmed">35769168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Ramachandram DS, Hasan SS. Coenzyme Q10 therapy in patients with post COVID-19 condition. Lancet Reg Health Eur. 2023;25:100567. 10.1016/j.lanepe.2022.100567. 10.1016/j.lanepe.2022.100567</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100567</ArticleId><ArticleId IdType="pmc">PMC9850420</ArticleId><ArticleId IdType="pubmed">36691396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen KS, Mogensen TH, Agergaard J, Schiottz-Christensen B, Ostergaard L, Vibholm LK, Leth S. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2023;24:100539. 10.1016/j.lanepe.2022.100539. 10.1016/j.lanepe.2022.100539</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100539</ArticleId><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clin Exp Med. 2023;23:667&#x2013;78. 10.1007/s10238-022-00871-8. 10.1007/s10238-022-00871-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00871-8</ArticleId><ArticleId IdType="pmc">PMC9395797</ArticleId><ArticleId IdType="pubmed">35994177</ArticleId></ArticleIdList></Reference><Reference><Citation>Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, Kujoth GC, et al. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci U S A. 2011;108:4135&#x2013;40. 10.1073/pnas.1019581108. 10.1073/pnas.1019581108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019581108</ArticleId><ArticleId IdType="pmc">PMC3053975</ArticleId><ArticleId IdType="pubmed">21368114</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro A, Gomez C, Lopez-Cepero JM, Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol Regul Integr Comp Physiol. 2004;286:R505-511. 10.1152/ajpregu.00208.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00208.2003</ArticleId><ArticleId IdType="pubmed">14615275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza IR, Nair KS. Muscle mitochondrial changes with aging and exercise. Am J Clin Nutr. 2009;89:467S-471S. 10.3945/ajcn.2008.26717D. 10.3945/ajcn.2008.26717D</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2008.26717D</ArticleId><ArticleId IdType="pmc">PMC2715293</ArticleId><ArticleId IdType="pubmed">19056588</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge S, Jang YM, Smith A, Selman C, Phillips T, Speakman JR, Hagen T, Leeuwenburgh C. Exercise by lifelong voluntary wheel running reduces subsarcolemmal and interfibrillar mitochondrial hydrogen peroxide production in the heart. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1564-1572. 10.1152/ajpregu.00396.2005. 10.1152/ajpregu.00396.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00396.2005</ArticleId><ArticleId IdType="pubmed">16051717</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos JC, Marchesi Bozi LH, Krum B, Grassmann Bechara LR, Ferreira ND, Arini GS, Albuquerque RP, Traa A, Ogawa T, van der Bliek AM, et al. Exercise preserves physical fitness during aging through AMPK and mitochondrial dynamics. Proc Natl Acad Sci U S A. 2023;120:e2204750120. 10.1073/pnas.2204750120. 10.1073/pnas.2204750120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2204750120</ArticleId><ArticleId IdType="pmc">PMC9926278</ArticleId><ArticleId IdType="pubmed">36595699</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>